longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Aspire Biopharma(ASBP.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Aspire Biopharma Announces 1-for-30 Reverse Stock Split

Tip Ranks·05/15/2026 05:12
US
ASBP
-12.72%
US
IBB
+0.10%
US
PBE
+0.11%
Tip Ranks·05/15/2026 05:12
US
ASBP
-12.72%
US
IBB
+0.10%
US
PBE
+0.11%

Aspire Biopharma Holdings Inc trading halted, news pending

businessinsider·05/09/2026 14:02
US
ASBP
-12.72%
US
BIB
+0.05%
US
IXJ
+0.79%
businessinsider·05/09/2026 14:02
US
ASBP
-12.72%
US
BIB
+0.05%
US
IXJ
+0.79%

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio | ASBP Stock News

StockTitan·05/07/2026 15:00
US
ASBP
-12.72%
US
IBB
+0.10%
US
VHT
+0.97%
StockTitan·05/07/2026 15:00
US
ASBP
-12.72%
US
IBB
+0.10%
US
VHT
+0.97%

Aspire Biopharma shares are trading higher after the company announced a $5 million share buyback program.

benzinga_article·04/28/2026 02:17
US
ASBP
-12.72%
benzinga_article·04/28/2026 02:17
US
ASBP
-12.72%

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga_article·04/22/2026 01:05
US
AIFF
0.00%
US
CMND
-37.83%
US
CUE
-5.05%
benzinga_article·04/22/2026 01:05
US
AIFF
0.00%
US
CMND
-37.83%
US
CUE
-5.05%

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

fidelity·04/20/2026 20:30
US
ASBP
-12.72%
US
IBB
+0.10%
US
BBH
+0.68%
fidelity·04/20/2026 20:30
US
ASBP
-12.72%
US
IBB
+0.10%
US
BBH
+0.68%
© 2026 Longbridge|Disclaimer

Event Tracking

May16
Aspire Biopharma released FY2026 Q1 earnings on May 15 (EST), actual revenue USD 28.35K, actual EPS USD -20.5692
03:00
Mar31
Aspire Biopharma released FY2025 earnings on March 30 (EST), actual revenue USD 6.202 K, actual EPS USD -491.2676
03:00
Aspire Biopharma released FY2025 Q4 earnings on March 30, 2026 (EST) with actual revenue of USD 4.261 K and EPS of USD -1.8422
03:00
Jan30
Aspire Biopharma Announces Private Equity Securities Sale
22:06
Dec4
Aspire Biopharma Reports Q3 2025 Business Update and Drug Development Progress
14:00
Nov15
Aspire Biopharma released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 1.941 K, actual EPS USD -0.0373
04:00

Schedules & Filings

Schedules
Filings
May15
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 28.35 K, Net Income -3.223 M, EPS -20.5692

May11
Reverse Stock Split(EST)

1-for-30 Reverse Stock Split

Mar30
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 4.261 K, Net Income -4.708 M, EPS -55.2674

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INM
1.600
+135.05%
+0.919
AMPGZ
0.5800
+132.00%
+0.330
AMST
1.730
+120.07%
+0.944
CNEY
1.610
+119.77%
+0.877
AMPGR
0.5000
+102.02%
+0.253
NXXT
0.8201
+100.02%
+0.410
WNW
4.750
+97.10%
+2.340
GIPR
0.4290
+75.89%
+0.185
MTVA
1.880
+69.37%
+0.770
SVRN
8.200
+49.64%
+2.720
View More